Preliminary Experience in Ultra-High Frequency Ultrasound Assessment of Cutaneous Primary Lymphomas: An Innovative Classification
- PMID: 39001518
- PMCID: PMC11240684
- DOI: 10.3390/cancers16132456
Preliminary Experience in Ultra-High Frequency Ultrasound Assessment of Cutaneous Primary Lymphomas: An Innovative Classification
Abstract
Background: Primary cutaneous lymphoma (PCL) is a rare form of extranodal non-Hodgkin's lymphoma characterized by malignant lymphocytes confined to the skin. Accurate diagnosis and staging are crucial for optimal management, yet radiological literature on imaging PCL remains limited. This study aims to delineate the imaging characteristics of PCLs using high and ultra-high frequency ultrasound (UHFUS) and proposes a classification system based on ultrasound findings.
Methods: A cohort of 88 individuals with suspected PCL underwent high-resolution ultrasound (HRUS) and color Doppler examination of lesions. Lesions were categorized based on sonographic appearance, and subsequent histopathological assessment confirmed the diagnosis.
Results: Ultrasound imaging revealed distinct patterns for primary cutaneous T-cell lymphomas (PCTCL) and primary cutaneous B-cell lymphomas (PCBCL), with characteristic features such as hypoechoic nodules, pseudonodular lesions, and dermal infiltration. Histopathological analysis confirmed the ultrasound findings, supporting the proposed classification system.
Conclusions: Ultrasonography, particularly UHFUS, offers valuable insights into the imaging characteristics of primary cutaneous lymphomas, aiding the accurate diagnosis and assessment of treatment response. The proposed classification system based on ultrasound findings enhances the diagnostic approach to PCLs, and paves the way for improved patient care and management strategies.
Keywords: high-frequency ultrasound; oncologic ultrasonography; primary cutaneous lymphoma; ultra-high frequency ultrasound.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Roccuzzo G., Giordano S., Fava P., Pileri A., Guglielmo A., Tonella L., Sanlorenzo M., Ribero S., Fierro M.T., Quaglino P. Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives. Front. Oncol. 2021;11:733770. doi: 10.3389/fonc.2021.733770. - DOI - PMC - PubMed
-
- Olsen E.A., Whittaker S., Willemze R., Pinter-Brown L., Foss F.M., Geskin L.J., Schwartz L.H., Horwitz S.M., Guitart J., Zic J., et al. Primary cutaneous lymphoma: Recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood. 2022;140:419–437. doi: 10.1182/blood.2021012057. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
